Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Clinical laboratory abnormalities.
D001219:Aspartate Aminotransferases / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D001806:Blood Urea Nitrogen; D003298:Coombs Test; D004295:Dihydroxyphenylalanine / Q000009:adverse effects*; D004562:Electrocardiography; D004569:Electroencephalography; D006400:Hematocrit; D006452:Hemoglobinometry; D006801:Humans; D007958:Leukocyte Count; D008111:Liver Function Tests; D010300:Parkinson Disease / Q000188:drug therapy*; D013960:Thyroid Function Tests; D014527:Uric Acid / Q000097:blood
D001786:Blood Glucose; D014527:Uric Acid; D004295:Dihydroxyphenylalanine; D001219:Aspartate Aminotransferases